MBIA (MBI) Downgrade by Moody’s. Falls to $25.84 from 52-week high of $76.02.

Genentech (DNA) FDA rejects key drug. Drops to $65.54 from 52-week high of $89.73.

AMD (AMD) More analyst concerns. Down to $8.83 from 52-week high of $23.

VeriFone (PAY) Still falling on bad accounting news. Down to $22.59 from 52-week high of $50.

AMR (AMR) High fuel prices put airlines out of favor. Drops to $18.36 from 52-week high of $41.

Comcast (CMCSA) Revises current year forecasts down. Falls to $18.08 from 52-week high of $30.18.

Douglas A. McIntyre